TickerFacts.

Fractyl Health, Inc. (GUTS): Cost of Revenue

Annual figures by period end, from SEC filings.

$0
Year ended 2025-12-31
$77.0K2023-12-31: $77.0K2024-12-31: $50.0K2025-12-31: $0$0
2023-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$0-100.0%2026-03-24, From 2025-01-01
2024-12-31$50.0K-35.1%2026-03-24, From 2024-01-01
2023-12-31$77.0Kn/a2025-03-03, From 2023-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Fractyl Health, Inc. (GUTS)2025-12-31$0-100.0%
Baxter International Inc (BAX)2025-12-31$7.87B+18.2%
Becton Dickinson & Co (BDX)2025-09-30$11.91B+7.8%
3M Co (MMM)2025-12-31$14.99B+3.8%
Teleflex Inc (TFX)2025-12-31$871.96M+31.7%
West Pharmaceutical Services Inc (WST)2025-12-31$1.97B+4.0%
Stryker Corp (SYK)2025-12-31$9.05B+11.0%
Haemonetics Corp (HAE)2026-03-28$546.44M-10.7%
KORU Medical Systems, Inc. (KRMD)2025-12-31$15.52M+26.1%

Compare GUTS, BAX, BDX, MMM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗